Peptide and peptide-based inhibitors of SARS-CoV-2 entry.

Volume: 167, Pages: 47 - 65
Published: Nov 13, 2020
Abstract
To date, no effective vaccines or therapies are available against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pandemic agent of the coronavirus disease 2019 (COVID-19). Due to their safety, efficacy and specificity, peptide inhibitors hold great promise for the treatment of newly emerging viral pathogens. Based on the known structures of viral proteins and their cellular targets, antiviral peptides can be...
Paper Details
Title
Peptide and peptide-based inhibitors of SARS-CoV-2 entry.
Published Date
Nov 13, 2020
Volume
167
Pages
47 - 65
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.